vs
汉瑞祥（HSIC）与Rocket Companies, Inc.（RKT）财务数据对比。点击上方公司名可切换其他公司
汉瑞祥的季度营收约是Rocket Companies, Inc.的1.3倍（$3.4B vs $2.7B），汉瑞祥净利率更高（2.9% vs 2.5%，领先0.4%），Rocket Companies, Inc.同比增速更快（52.2% vs 7.7%），汉瑞祥自由现金流更多（$338.0M vs $-1.3B），过去两年Rocket Companies, Inc.的营收复合增速更高（39.5% vs 4.1%）
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
Rocket Companies, Inc.是美国金融科技及住房服务企业，由丹·吉尔伯特创立，总部位于密歇根州底特律市中心。公司依托旗舰子公司Rocket Mortgage跻身美国最大抵押贷款提供商行列，旗下还拥有Redfin、Forsalebyowner.com、Rocket Money等子品牌。
HSIC vs RKT — 直观对比
营收规模更大
HSIC
是对方的1.3倍
$2.7B
营收增速更快
RKT
高出44.4%
7.7%
净利率更高
HSIC
高出0.4%
2.5%
自由现金流更多
HSIC
多$1.6B
$-1.3B
两年增速更快
RKT
近两年复合增速
4.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.4B | $2.7B |
| 净利润 | $101.0M | $68.0M |
| 毛利率 | 30.9% | — |
| 营业利润率 | 4.7% | 6.3% |
| 净利率 | 2.9% | 2.5% |
| 营收同比 | 7.7% | 52.2% |
| 净利润同比 | 7.4% | 100.8% |
| 每股收益（稀释后） | $0.85 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSICRKT
| Q4 25 | $3.4B | $2.7B | ||
| Q3 25 | $3.3B | $1.6B | ||
| Q2 25 | $3.2B | $1.4B | ||
| Q1 25 | $3.2B | $1.0B | ||
| Q4 24 | $3.2B | $1.8B | ||
| Q3 24 | $3.2B | $646.9M | ||
| Q2 24 | $3.1B | $1.3B | ||
| Q1 24 | $3.2B | $1.4B |
净利润HSICRKT
| Q4 25 | $101.0M | $68.0M | ||
| Q3 25 | $101.0M | $-123.9M | ||
| Q2 25 | $86.0M | $-1.8M | ||
| Q1 25 | $110.0M | $-10.4M | ||
| Q4 24 | $94.0M | $33.9M | ||
| Q3 24 | $99.0M | $-22.0M | ||
| Q2 24 | $104.0M | $1.3M | ||
| Q1 24 | $93.0M | $16.2M |
毛利率HSICRKT
| Q4 25 | 30.9% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.4% | — | ||
| Q1 25 | 31.6% | — | ||
| Q4 24 | 31.1% | 58.9% | ||
| Q3 24 | 31.3% | -8.4% | ||
| Q2 24 | 32.5% | 47.4% | ||
| Q1 24 | 31.9% | 51.2% |
营业利润率HSICRKT
| Q4 25 | 4.7% | 6.3% | ||
| Q3 25 | 4.9% | -11.5% | ||
| Q2 25 | 4.7% | 1.8% | ||
| Q1 25 | 5.5% | -21.5% | ||
| Q4 24 | 4.9% | 38.1% | ||
| Q3 24 | 4.9% | -76.9% | ||
| Q2 24 | 5.1% | 14.8% | ||
| Q1 24 | 4.7% | 21.6% |
净利率HSICRKT
| Q4 25 | 2.9% | 2.5% | ||
| Q3 25 | 3.0% | -7.7% | ||
| Q2 25 | 2.7% | -0.1% | ||
| Q1 25 | 3.5% | -1.0% | ||
| Q4 24 | 2.9% | 1.9% | ||
| Q3 24 | 3.1% | -3.4% | ||
| Q2 24 | 3.3% | 0.1% | ||
| Q1 24 | 2.9% | 1.2% |
每股收益（稀释后）HSICRKT
| Q4 25 | $0.85 | $0.10 | ||
| Q3 25 | $0.84 | $-0.06 | ||
| Q2 25 | $0.70 | $-0.01 | ||
| Q1 25 | $0.88 | $-0.08 | ||
| Q4 24 | $0.75 | $0.28 | ||
| Q3 24 | $0.78 | $-0.19 | ||
| Q2 24 | $0.80 | $0.01 | ||
| Q1 24 | $0.72 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.0M | $2.7B |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $3.2B | $22.9B |
| 总资产 | $11.2B | $60.7B |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
现金及短期投资HSICRKT
| Q4 25 | $156.0M | $2.7B | ||
| Q3 25 | $136.0M | $5.8B | ||
| Q2 25 | $145.0M | $5.1B | ||
| Q1 25 | $127.0M | $1.4B | ||
| Q4 24 | $122.0M | $1.3B | ||
| Q3 24 | $126.0M | $1.2B | ||
| Q2 24 | $138.0M | $1.3B | ||
| Q1 24 | $159.0M | $861.4M |
总债务HSICRKT
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $2.0B | — |
股东权益HSICRKT
| Q4 25 | $3.2B | $22.9B | ||
| Q3 25 | $3.4B | $8.9B | ||
| Q2 25 | $3.4B | $7.4B | ||
| Q1 25 | $3.3B | $8.6B | ||
| Q4 24 | $3.4B | $9.0B | ||
| Q3 24 | $3.5B | $8.4B | ||
| Q2 24 | $3.5B | $8.8B | ||
| Q1 24 | $3.6B | $8.6B |
总资产HSICRKT
| Q4 25 | $11.2B | $60.7B | ||
| Q3 25 | $11.1B | $33.6B | ||
| Q2 25 | $10.9B | $30.4B | ||
| Q1 25 | $10.5B | $25.3B | ||
| Q4 24 | $10.2B | $24.5B | ||
| Q3 24 | $10.6B | $25.1B | ||
| Q2 24 | $10.3B | $23.6B | ||
| Q1 24 | $10.1B | $22.2B |
负债/权益比HSICRKT
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.64× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.54× | — | ||
| Q1 24 | 0.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $381.0M | $-1.2B |
| 自由现金流经营现金流 - 资本支出 | $338.0M | $-1.3B |
| 自由现金流率自由现金流/营收 | 9.8% | -47.2% |
| 资本支出强度资本支出/营收 | 1.3% | 1.5% |
| 现金转化率经营现金流/净利润 | 3.77× | -18.08× |
| 过去12个月自由现金流最近4个季度 | $573.0M | $-4.0B |
8季度趋势，按日历期对齐
经营现金流HSICRKT
| Q4 25 | $381.0M | $-1.2B | ||
| Q3 25 | $174.0M | $-50.3M | ||
| Q2 25 | $120.0M | $-1.9B | ||
| Q1 25 | $37.0M | $-797.0M | ||
| Q4 24 | $204.0M | $1.8B | ||
| Q3 24 | $151.0M | $-1.3B | ||
| Q2 24 | $296.0M | $-122.3M | ||
| Q1 24 | $197.0M | $-3.0B |
自由现金流HSICRKT
| Q4 25 | $338.0M | $-1.3B | ||
| Q3 25 | $141.0M | $-71.8M | ||
| Q2 25 | $88.0M | $-1.9B | ||
| Q1 25 | $6.0M | $-811.0M | ||
| Q4 24 | $168.0M | $1.8B | ||
| Q3 24 | $117.0M | $-1.4B | ||
| Q2 24 | $259.0M | $-138.3M | ||
| Q1 24 | $156.0M | $-3.0B |
自由现金流率HSICRKT
| Q4 25 | 9.8% | -47.2% | ||
| Q3 25 | 4.2% | -4.5% | ||
| Q2 25 | 2.7% | -137.2% | ||
| Q1 25 | 0.2% | -78.2% | ||
| Q4 24 | 5.3% | 103.1% | ||
| Q3 24 | 3.7% | -209.6% | ||
| Q2 24 | 8.3% | -10.6% | ||
| Q1 24 | 4.9% | -218.7% |
资本支出强度HSICRKT
| Q4 25 | 1.3% | 1.5% | ||
| Q3 25 | 1.0% | 1.3% | ||
| Q2 25 | 1.0% | 1.1% | ||
| Q1 25 | 1.0% | 1.4% | ||
| Q4 24 | 1.1% | 1.1% | ||
| Q3 24 | 1.1% | 2.9% | ||
| Q2 24 | 1.2% | 1.2% | ||
| Q1 24 | 1.3% | 1.0% |
现金转化率HSICRKT
| Q4 25 | 3.77× | -18.08× | ||
| Q3 25 | 1.72× | — | ||
| Q2 25 | 1.40× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 2.17× | 54.42× | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 2.85× | -94.46× | ||
| Q1 24 | 2.12× | -185.80× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
RKT
| Other | $1.4B | 51% |
| Direct To Customer Segment | $945.8M | 35% |
| Partner Network Segment | $216.7M | 8% |
| Subscription Revenue | $91.3M | 3% |
| Closing Fees | $47.1M | 2% |
| Appraisal Revenue | $10.7M | 0% |
